Effects of anti-parkinsonian drugs on the motor activity and EEG of cats with subthalamic lesions.
D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D001288:Attention / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001545:Benserazide / Q000494:pharmacology; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology; D003344:Cortical Synchronization; D003913:Dextroamphetamine / Q000494:pharmacology; D004027:Diencephalon / Q000187:drug effects / Q000502:physiology*; D004569:Electroencephalography; D007839:Functional Laterality / Q000502:physiology; D007980:Levodopa / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D009434:Neural Pathways; D012154:Reticular Formation / Q000502:physiology
D000978:Antiparkinson Agents; D007980:Levodopa; D001545:Benserazide; D000547:Amantadine; D003913:Dextroamphetamine